Abbott (ABT) Tops Q4 EPS by 1c, FY16 EPS Falls Short of Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
UBS Remains Neutral on Abbott (ABT) Following 4Q Earnings and Conference Call
February 1, 2016 8:33 AM ESTUBS maintained a Neutral rating on Abbott Labs (NYSE: ABT), and cut the price target to $41.00 (from $43.00), following the company's 4Q earnings report. Street estimates suggested a lower 2016 outlook, driven by tougher FX in geographies where ABT has fewer natural hedges. However, the volume slowdown in oildriven economies like Venezuela took another dime or so out of the 2016 EPS... More
William Blair Downgrades Abbott Labs (ABT) to Market Perform
January 29, 2016 7:28 AM ESTWilliam Blair downgraded Abbott Labs (NYSE: ABT) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Abbott Labs click here. For more ratings news on Abbott Labs click here.
Shares of Abbott Labs closed at $36.71 yesterday.
... More